Loading…
Micro-titration of depot neuroleptic dosages
Depot neuroleptic treatments can be compromised by side-effects unacceptable to users or, more seriously, by tardive dyskinesia (TD). Neuroleptic dosages can be lowered to increase acceptability and decrease the Incidence of TD, but with a greater likelihood of relapse. One argument proposes that ma...
Saved in:
Published in: | Psychiatric bulletin of the Royal College of Psychiatrists 1996-11, Vol.20 (11), p.660-661 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Depot neuroleptic treatments can be compromised by side-effects unacceptable to users or, more seriously, by tardive dyskinesia (TD). Neuroleptic dosages can be lowered to increase acceptability and decrease the Incidence of TD, but with a greater likelihood of relapse. One argument proposes that many patients changing to lower dosages break down because withdrawal from a neuroleptic is stressful in itself. Research suggests that withdrawal regimes should be radically cautious. A computer tool is offered which can aid clinicians in calculating small reductions. |
---|---|
ISSN: | 1758-3209 0955-6036 1758-3217 1472-1473 |
DOI: | 10.1192/pb.20.11.660 |